Patents by Inventor David H. Weinberg

David H. Weinberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
    Patent number: 7029865
    Abstract: The present invention relates to rhesus monkey DNA molecules encoding the melanocortin-4 receptor protein, recombinant vectors comprising DNA molecules encoding rhesus MC-4R, recombinant host cells which contain a recombinant vectors encoding rhesus MC-4R, the rhesus MC-4R protein encoded by the DNA molecule, and methods of identifying selective agonists and antagonists of rhesus MC-4R.
    Type: Grant
    Filed: February 25, 2003
    Date of Patent: April 18, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Douglas J. MacNeil, David H. Weinberg, Leonardus H. T. Van Der Ploeg
  • DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
    Publication number: 20030166009
    Abstract: The present invention relates to rhesus monkey DNA molecules encoding the melanocortin-4 receptor protein, recombinant vectors comprising DNA molecules encoding rhesus MC-4R, recombinant host cells which contain a recombinant vectors encoding rhesus MC-4R, the rhesus MC-4R protein encoded by the DNA molecule, and methods of identifying selective agonists and antagonists of rhesus MC-4R.
    Type: Application
    Filed: February 25, 2003
    Publication date: September 4, 2003
    Inventors: Douglas J. MacNeil, David H. Weinberg, Leonardus H. T. Van Der Ploeg
  • DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
    Patent number: 6573070
    Abstract: The present invention relates to rhesus monkey DNA molecules encoding the melanocortin-4 receptor protein, recombinant vectors comprising DNA molecules encoding rhesus MC-4R, recombinant host cells which contain a recombinant vectors encoding rhesus MC-4R, the rhesus MC-4R protein encoded by the DNA molecule, and methods of identifying selective agonists and antagonists of rhesus MC-4R.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: June 3, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Douglas J. MacNeil, David H. Weinberg, Leonardus H. T. Van Der Ploeg
  • Neuropeptide Y receptor
    Patent number: 5939263
    Abstract: A novel mammalian neuropeptide Y receptor and method of making the receptor are provided. The invention includes DNA encoding the receptor, the receptor, assays employing the receptor, cells expressing the receptor, antibodies which bind specifically to the receptor, RNA encoded by the DNA sequence or its complementary sequence, and single-stranded DNA with a sequence complementary to the RNA which encodes the receptor. The receptor and assays employing the receptor are useful for identifying compounds which bind to the receptor, including specific modulators of the receptor. Such compounds are useful for treating a variety of disease conditions, including obesity, diabetes, anxiety, hypertension, cocaine withdrawal, congestive heart failure, memory enhancement, cardiac and cerebral vasospasm, pheochromocytoma and ganglioneuroblastoma, and Huntington's, Alzheimer's and Parkinson's diseases.
    Type: Grant
    Filed: July 25, 1997
    Date of Patent: August 17, 1999
    Assignee: Merck & Co., Ltd.
    Inventors: Margaret A. Cascieri, Douglas J. MacNeil, Lin-Lin Shiao, David H. Weinberg, Carina P. Tan, David L. Linemeyer, Catherine D. Strader
  • Neuropeptide Y receptor
    Patent number: 5621079
    Abstract: A novel mammalian neuropeptide Y receptor and method of making the receptor are provided. The invention includes DNA encoding the receptor, the receptor, assays employing the receptor, cells expressing the receptor, antibodies which bind specifically to the receptor, RNA encoded by the DNA sequence or its complementary sequence, and single-stranded DNA with a sequence complementary to the RNA which encodes the receptor. The receptor and assays employing the receptor are useful for identifying compounds which bind to the receptor, including specific modulators of the receptor. Such compounds are useful for treating a variety of disease conditions, including obesity, diabetes, anxiety, hypertension, cocaine withdrawal, congestive heart failure, memory enhancement, cardiac and cerebral vasospasm, pheochromocytoma and ganglioneuroblastoma, and Huntington's, Alzheimer's and Parkinson's diseases.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: April 15, 1997
    Assignee: Merck & Co., Inc.
    Inventors: Margaret A. Cascieri, David L. Linemeyer, Douglas J. Macneil, Lin-Lin Shiao, Catherine D. Strader, David H. Weinberg, Carina P. Tan